1. Home
  2. CING vs UONEK Comparison

CING vs UONEK Comparison

Compare CING & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • UONEK
  • Stock Information
  • Founded
  • CING 2012
  • UONEK 1980
  • Country
  • CING United States
  • UONEK United States
  • Employees
  • CING N/A
  • UONEK N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • UONEK Broadcasting
  • Sector
  • CING Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • CING 26.7M
  • UONEK 28.1M
  • IPO Year
  • CING 2021
  • UONEK N/A
  • Fundamental
  • Price
  • CING $4.04
  • UONEK $0.73
  • Analyst Decision
  • CING Strong Buy
  • UONEK
  • Analyst Count
  • CING 4
  • UONEK 0
  • Target Price
  • CING $30.67
  • UONEK N/A
  • AVG Volume (30 Days)
  • CING 173.5K
  • UONEK 24.0K
  • Earning Date
  • CING 08-26-2025
  • UONEK 08-13-2025
  • Dividend Yield
  • CING N/A
  • UONEK N/A
  • EPS Growth
  • CING N/A
  • UONEK N/A
  • EPS
  • CING N/A
  • UONEK N/A
  • Revenue
  • CING N/A
  • UONEK $411,386,000.00
  • Revenue This Year
  • CING N/A
  • UONEK N/A
  • Revenue Next Year
  • CING N/A
  • UONEK N/A
  • P/E Ratio
  • CING N/A
  • UONEK N/A
  • Revenue Growth
  • CING N/A
  • UONEK N/A
  • 52 Week Low
  • CING $3.02
  • UONEK $0.44
  • 52 Week High
  • CING $20.83
  • UONEK $1.44
  • Technical
  • Relative Strength Index (RSI)
  • CING 40.42
  • UONEK 59.20
  • Support Level
  • CING $3.50
  • UONEK $0.63
  • Resistance Level
  • CING $4.31
  • UONEK $0.69
  • Average True Range (ATR)
  • CING 0.46
  • UONEK 0.04
  • MACD
  • CING -0.15
  • UONEK 0.01
  • Stochastic Oscillator
  • CING 24.11
  • UONEK 73.45

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: